Hwanin Pharmaceutical Reports 15% Decrease in Q2 Sales and Operating Profit

[Asia Economy Reporter Ji Yeon-jin] Hwanin Pharmaceutical announced on the 29th that its sales in the second quarter of this year reached 48.5 billion KRW, a 14% increase compared to the same period last year.

During this period, operating profit decreased by 15.7% to 6.4 billion KRW, and net profit for the period fell by 21.1% to approximately 5.3 billion KRW.